Non-Current Assets
Deferred Tax Assets
Gilead Sciences Deferred Tax Assets decreased by 55.5% to $179M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 74.8%, from $709M to $179M. Over 4 years (FY 2021 to FY 2025), Deferred Tax Assets shows a downward trend with a -39.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 7, 2026
How to read this metric
An increase may signal future tax savings, while a decrease could indicate the utilization of tax credits or changes in tax valuation allowances.
Detailed definition
These are future tax benefits that arise from temporary differences between the book value of assets/liabilities and the...
Peer comparison
Standard across all industries; highly dependent on specific tax jurisdictions and historical performance.
Metric ID:
deferred_tax_assetsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.37B | $4.6B | $4.36B | $3.69B | $3.36B | $3.04B | $2.67B | $2.4B | $2.11B | $1.98B | $1.59B | $933M | $907M | $794M | $724M | $709M | $652M | $597M | $402M | $179M |
| QoQ Change | — | +5.2% | -5.4% | -15.4% | -8.8% | -9.8% | -12.0% | -10.2% | -12.3% | -5.8% | -20.0% | -41.2% | -2.8% | -12.5% | -8.8% | -2.1% | -8.0% | -8.4% | -32.7% | -55.5% |
| YoY Change | — | — | — | — | -23.1% | -34.0% | -38.6% | -34.9% | -37.4% | -34.7% | -40.6% | -61.1% | -56.9% | -60.0% | -54.4% | -24.0% | -28.1% | -24.8% | -44.5% | -74.8% |
Range$179M – $4.6B
CAGR-49.0%
Avg YoY Growth-42.0%
Median YoY Growth-38.0%
Current Streak18 quarters decline
Deferred Tax Assets at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's deferred tax assets?
- Gilead Sciences (GILD) reported deferred tax assets of $179M in Q1 2026.
- How has Gilead Sciences's deferred tax assets changed year-over-year?
- Gilead Sciences's deferred tax assets decreased by 74.8% year-over-year, from $709M to $179M.
- What is the long-term trend for Gilead Sciences's deferred tax assets?
- Over 4 years (2021 to 2025), Gilead Sciences's deferred tax assets has grown at a -39.7% compound annual growth rate (CAGR), from $17.8B to $2.36B.
- What does deferred tax assets mean?
- Future tax savings that the company expects to realize based on past accounting or tax events.